Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
26.56
-0.24 (-0.90%)
Apr 9, 2026, 3:00 PM CST
SHA:600196 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 13,104 | 13,524 | 13,694 | 16,241 | 10,317 |
Trading Asset Securities | 2,254 | 2,596 | 1,888 | 928.53 | 4,241 |
Cash & Short-Term Investments | 15,358 | 16,120 | 15,582 | 17,170 | 14,558 |
Cash Growth | -4.73% | 3.45% | -9.25% | 17.94% | 22.01% |
Accounts Receivable | 9,955 | 8,765 | 8,457 | 8,172 | 6,474 |
Other Receivables | 712.79 | 676.66 | 636.27 | 611.57 | 875.26 |
Receivables | 10,668 | 9,442 | 9,093 | 8,783 | 7,538 |
Inventory | 6,252 | 7,259 | 7,538 | 6,882 | 5,473 |
Other Current Assets | 1,543 | 1,671 | 1,580 | 2,443 | 2,868 |
Total Current Assets | 33,821 | 34,491 | 33,793 | 35,279 | 30,437 |
Property, Plant & Equipment | 24,084 | 23,411 | 22,239 | 16,028 | 13,284 |
Long-Term Investments | 27,269 | 25,865 | 25,012 | 25,549 | 23,920 |
Goodwill | 10,810 | 10,905 | 10,852 | 10,337 | 9,400 |
Other Intangible Assets | 13,999 | 14,468 | 13,482 | 12,471 | 10,276 |
Long-Term Accounts Receivable | 213.33 | 198.83 | 83.01 | 91.66 | 77.4 |
Long-Term Deferred Tax Assets | 985.34 | 757.78 | 624.47 | 442.57 | 265.59 |
Long-Term Deferred Charges | 7,593 | 6,250 | 4,675 | 4,008 | 3,632 |
Other Long-Term Assets | 1,280 | 1,114 | 2,512 | 2,836 | 2,014 |
Total Assets | 120,054 | 117,461 | 113,470 | 107,164 | 93,306 |
Accounts Payable | 5,144 | 5,997 | 6,160 | 6,284 | 5,064 |
Accrued Expenses | 5,649 | 5,408 | 5,414 | 5,577 | 4,807 |
Short-Term Debt | 15,530 | 18,711 | 14,728 | 11,932 | 10,629 |
Current Portion of Long-Term Debt | 5,635 | 3,983 | 4,422 | 5,230 | 4,986 |
Current Portion of Leases | 348.4 | 340.98 | 329.53 | 184.41 | 141.5 |
Current Income Taxes Payable | 253.91 | 278.7 | 250.63 | 619.34 | 474.22 |
Current Unearned Revenue | 1,300 | 1,232 | 1,200 | 1,545 | 1,154 |
Other Current Liabilities | 2,563 | 1,501 | 1,253 | 1,928 | 2,063 |
Total Current Liabilities | 36,424 | 37,453 | 33,758 | 33,298 | 29,318 |
Long-Term Debt | 11,862 | 10,444 | 13,505 | 12,100 | 9,049 |
Long-Term Leases | 3,051 | 2,542 | 2,050 | 744.99 | 648.36 |
Long-Term Unearned Revenue | 1,742 | 1,093 | 959.18 | 986.85 | 751.82 |
Long-Term Deferred Tax Liabilities | 3,260 | 3,245 | 3,445 | 3,363 | 3,130 |
Other Long-Term Liabilities | 1,874 | 2,751 | 3,137 | 2,562 | 2,029 |
Total Liabilities | 58,214 | 57,527 | 56,853 | 53,055 | 44,927 |
Common Stock | 2,670 | 2,671 | 2,672 | 2,672 | 2,563 |
Additional Paid-In Capital | 16,377 | 16,591 | 16,853 | 16,992 | 14,041 |
Retained Earnings | 32,071 | 29,545 | 27,501 | 26,170 | 23,858 |
Treasury Stock | -607.96 | -234.38 | -41.93 | -53.25 | - |
Comprehensive Income & Other | -1,769 | -1,313 | -1,300 | -1,198 | -1,266 |
Total Common Equity | 48,742 | 47,261 | 45,685 | 44,582 | 39,196 |
Minority Interest | 13,099 | 12,673 | 10,931 | 9,526 | 9,184 |
Shareholders' Equity | 61,840 | 59,934 | 56,616 | 54,109 | 48,380 |
Total Liabilities & Equity | 120,054 | 117,461 | 113,470 | 107,164 | 93,306 |
Total Debt | 36,427 | 36,021 | 35,035 | 30,191 | 25,454 |
Net Cash (Debt) | -21,069 | -19,901 | -19,453 | -13,021 | -10,896 |
Net Cash Per Share | -7.96 | -7.45 | -7.29 | -4.99 | -4.25 |
Filing Date Shares Outstanding | 2,640 | 2,657 | 2,672 | 2,672 | 2,563 |
Total Common Shares Outstanding | 2,640 | 2,658 | 2,672 | 2,672 | 2,563 |
Working Capital | -2,604 | -2,962 | 34.99 | 1,981 | 1,118 |
Book Value Per Share | 18.47 | 17.78 | 17.10 | 16.68 | 15.29 |
Tangible Book Value | 23,933 | 21,888 | 21,351 | 21,774 | 19,519 |
Tangible Book Value Per Share | 9.07 | 8.23 | 7.99 | 8.15 | 7.62 |
Land | 1,021 | 943.68 | 951.74 | 201.31 | 203.68 |
Buildings | 14,061 | 12,927 | 11,471 | 7,733 | 6,605 |
Machinery | 16,347 | 15,392 | 14,026 | 10,700 | 9,197 |
Construction In Progress | 3,055 | 3,435 | 4,938 | 4,897 | 3,618 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.